InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.394
+0.004 (0.29%)
Oct 30, 2025, 11:37 AM EDT - Market open

InterCure Statistics

Total Valuation

InterCure has a market cap or net worth of $79.09 million. The enterprise value is $118.75 million.

Market Cap79.09M
Enterprise Value 118.75M

Important Dates

The last earnings date was Wednesday, October 8, 2025, before market open.

Earnings Date Oct 8, 2025
Ex-Dividend Date n/a

Share Statistics

InterCure has 54.51 million shares outstanding. The number of shares has increased by 8.85% in one year.

Current Share Class 54.51M
Shares Outstanding 54.51M
Shares Change (YoY) +8.85%
Shares Change (QoQ) +29.17%
Owned by Insiders (%) 36.44%
Owned by Institutions (%) 6.01%
Float 34.65M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.10
Forward PS 0.37
PB Ratio 0.62
P/TBV Ratio 1.29
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.65
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.41.

Current Ratio 1.85
Quick Ratio 1.08
Debt / Equity 0.41
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.41

Financial Efficiency

Return on equity (ROE) is -16.68% and return on invested capital (ROIC) is -9.43%.

Return on Equity (ROE) -16.68%
Return on Assets (ROA) -7.74%
Return on Invested Capital (ROIC) -9.43%
Return on Capital Employed (ROCE) -16.81%
Revenue Per Employee $225,495
Profits Per Employee -$65,789
Employee Count320
Asset Turnover 0.33
Inventory Turnover 1.47

Taxes

Income Tax -4.90M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -19.65% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -19.65%
50-Day Moving Average 1.57
200-Day Moving Average 1.55
Relative Strength Index (RSI) 36.54
Average Volume (20 Days) 37,814

Short Selling Information

The latest short interest is 10,301, so 0.02% of the outstanding shares have been sold short.

Short Interest 10,301
Short Previous Month 24,304
Short % of Shares Out 0.02%
Short % of Float 0.03%
Short Ratio (days to cover) 0.08

Income Statement

In the last 12 months, InterCure had revenue of $72.16 million and -$21.05 million in losses. Loss per share was -$0.42.

Revenue72.16M
Gross Profit 12.05M
Operating Income -27.42M
Pretax Income -27.04M
Net Income -21.05M
EBITDA -23.93M
EBIT -27.42M
Loss Per Share -$0.42
Full Income Statement

Balance Sheet

The company has $15.31 million in cash and $53.23 million in debt, giving a net cash position of -$37.92 million or -$0.70 per share.

Cash & Cash Equivalents 15.31M
Total Debt 53.23M
Net Cash -37.92M
Net Cash Per Share -$0.70
Equity (Book Value) 128.29M
Book Value Per Share 2.25
Working Capital 51.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$3.34 million and capital expenditures -$2.16 million, giving a free cash flow of -$5.69 million.

Operating Cash Flow -3.34M
Capital Expenditures -2.16M
Free Cash Flow -5.69M
FCF Per Share -$0.10
Full Cash Flow Statement

Margins

Gross margin is 16.71%, with operating and profit margins of -38.01% and -29.18%.

Gross Margin 16.71%
Operating Margin -38.01%
Pretax Margin -37.47%
Profit Margin -29.18%
EBITDA Margin -33.16%
EBIT Margin -38.01%
FCF Margin n/a

Dividends & Yields

InterCure does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -8.85%
Shareholder Yield -8.85%
Earnings Yield -26.62%
FCF Yield -7.19%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

InterCure has an Altman Z-Score of 0.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.21
Piotroski F-Score 2